Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Ariceum Therapeutics GmbH
Ocellaris Pharma, Inc.
Regeneron Pharmaceuticals
Transgene
NeoImmuneTech
Incyte Corporation
Pfizer
University of Virginia
Fred Hutchinson Cancer Center
Washington University School of Medicine
ImmunityBio, Inc.
ImmunityBio, Inc.
University of Florida
Fate Therapeutics
Fate Therapeutics
Fate Therapeutics
Dana-Farber Cancer Institute
Xencor, Inc.
Pfizer
Nektar Therapeutics
Genocea Biosciences, Inc.
Exicure, Inc.
Fred Hutchinson Cancer Center
Stanford University
Incyte Corporation
Philogen S.p.A.
Fred Hutchinson Cancer Center
Yale University